Winner Medical receives EPO approval for PurCotton production method
28 Feb '09
2 min read
Winner Medical Group Inc announced that the European Patent Office has decided to grant the patent for producing PurCotton products to Winner Medical. The following are specifically covered by the patent: method for producing spunlace non-woven cloth, method for producing spunlace non-woven cloth with X-ray detectable element and spunlace non-woven cloth with X-ray detectable element produced thereby.
Mr. Jianquan Li, CEO of Winner Medical, remarked, "This means the achievement of another important milestone. The European patent enables us to plan on a long-term basis and to advance the market entry for our PurCotton products steadily. Now we have valid national rights in approximately 34 member states of the European Patent Office."
As of February 2009, Winner Medical has obtained patents for PurCotton products in several countries, including China, the U.S.A., Russia, Singapore, South Africa, and 34 member states of the European Patent Office. The patent application is also pending in other regions such as Japan, South America, India and the Middle East.
PurCotton products combine the superior characteristics of both natural cotton and materials made using nonwoven technology. It has many advantages over both woven cotton and synthetic nonwoven fabric, as it is of high quality, natural, safe, strong, durable, healthy and environmentally-friendly.
Winner Medical's patented manufacturing process enables the Company to produce PurCotton at a lower cost than the woven cotton products, and it can therefore offer customers a lower price without sacrificing its margin. The Company expects the new PurCotton products to be a medium to long term growth contributor to its revenue.
20240830145952.gif)
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "UBM China (Shanghai)")
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
